What is he best known for?
The fields of study he is best known for:
His primary areas of study are Genetics, Gene, Genome, Mutation and Germline mutation.
Genomics, Carcinogenesis, MicroRNA sequencing, Exome and Genetic heterogeneity are the core of his Genetics study.
Gene and Serous fluid are frequently intertwined in his study.
The various areas that he examines in his Mutation study include Leukemia and Myeloid leukemia.
His biological study deals with issues like Cancer research, which deal with fields such as Serous carcinoma.
As a part of the same scientific study, Michael D. McLellan usually deals with the Germline mutation, concentrating on Adenocarcinoma and frequently concerns with Exon and MLH1.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (5484 citations)
- Integrated genomic analyses of ovarian carcinoma (4769 citations)
What are the main themes of his work throughout his whole career to date?
Genetics, Gene, Cancer research, Genome and Computational biology are his primary areas of study.
His work in Genetics addresses subjects such as Myeloid leukemia, which are connected to disciplines such as Leukemia and Enasidenib.
The study incorporates disciplines such as Cancer and Molecular biology in addition to Gene.
His Cancer research research is multidisciplinary, incorporating elements of KRAS, microRNA, Serous fluid and PTEN.
In his study, Comparative genomic hybridization is inextricably linked to SNP array, which falls within the broad field of Genome.
Michael D. McLellan studied Genomics and Exome that intersect with Genetic heterogeneity.
He most often published in these fields:
- Genetics (50.00%)
- Gene (33.33%)
- Cancer research (24.60%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (24.60%)
- Genetics (50.00%)
- Computational biology (14.29%)
In recent papers he was focusing on the following fields of study:
Michael D. McLellan focuses on Cancer research, Genetics, Computational biology, Germline mutation and Genome.
His Cancer research research includes themes of Thymic carcinoma, Thymoma, microRNA and Oncogene.
His Computational biology research incorporates elements of Exome sequencing, Exome and Hpv genotypes.
In his research on the topic of Germline mutation, Carcinogenesis, PALB2, Loss of heterozygosity, Genetic testing and Allele frequency is strongly related with Germline.
His work deals with themes such as Gene duplication, Chromosome instability and Chromosome 3, which intersect with Genome.
His study in Whole genome sequencing is interdisciplinary in nature, drawing from both Point mutation, Genomics, Chromothripsis, Exon and Massive parallel sequencing.
Between 2016 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas (327 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cancer research, Germline mutation, Genomics, microRNA and Oncogene.
His Cancer research research focuses on subjects like Transcription factor, which are linked to Non-coding RNA.
His Germline mutation research is included under the broader classification of Genetics.
He integrates many fields, such as Genetics and SDHA, in his works.
As a member of one scientific family, Michael D. McLellan mostly works in the field of Genomics, focusing on Computational biology and, on occasion, Exome sequencing and Exome.
Michael D. McLellan has researched Oncogene in several fields, including Chromatin, PTEN, Carcinogenesis and Proto-Oncogene Proteins c-myc.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
